EGFR and colorectal carcinoma: Lately, it has been observed in an in vitro study that cetuximab treatment in many cancer cell lines, including CRC, stimulates cytoprotective autophagy through the inhibition of EGFR/PI3K/mTOR signaling pathway (200).